US Patent Issued to Foghorn Therapeutics on Feb. 17 for "Compounds and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,775, issued on Feb. 17, was assigned to Foghorn Therapeutics Inc. (Cambridge, Mass.).

"Compounds and uses thereof" was invented by Matthew Netherton (Cambridge, Mass.), Francois Brucelle (Belmont, Mass.), Jing Deng (Cambridge, Mass.) and Johannes H. Voigt (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure features compounds and methods useful for the treatment of BAF complex-related disorders."

The patent was filed on Nov. 22, 2021, under Application No. 18/253,526.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&...